Minimal residual disease negativity was achieved at a significantly higher rate with venetoclax-based therapies, supporting its role in CLL.

Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

Black Americans face higher rates and lower survival. Research explores biological, social factors, and disparities.

Actinium Pharma inks research pact with Memorial Sloan Kettering to support further clinical expansion of Actimab-A's backbone therapy strategy: New York Saturday, March 22, 2025, ...

Pharos iBio announced on the 21st that it has signed a memorandum of understanding (MOU) for the development of companion ...

This surge reflects the increasing reliance on genetic diagnostics for identifying hereditary diseases, guiding cancer ...

A study of 200 patients with chronic lymphocytic leukemia (CLL) showed a lower rate of severe and serious adverse events ...

大家好，我是河南省肿瘤医院赵艳秋医生。CROWN研究是一项国际、多中心、开放标签、III期临床试验，旨在评估洛拉替尼 vs 克唑替尼在初治的晚期ALK阳性NSCLC患者中的疗效与安全性。主要终点为盲法独立评审委员会（BICR）评估的无进展生存（PFS ...

In a case report published in the World Journal of Oncology, an elderly female patient was diagnosed with mast cell leukemia (MCL), with imaging showing extensive osteoblastic metastatic lesions. MCL ...

Genetic and genomic testing guide breast cancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami ...

The mysterious Greenland shark has an unusually long lifespan, and scientists are beginning to think they finally know why.